Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A small molecule inhibitor of NVL suppresses tumor growth by blocking ribosome biogenesis.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Correction to "Thiophenyl Derivatives of Nicotinamide Are Metabolized by the NAD Salvage Pathway into Unnatural NAD Derivatives That Inhibit IMPDH and Are Toxic to Peripheral Nerve Cancers".
Journal: ACS chemical biology
Published: July 01, 2025
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2024
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.
Journal: Nature
Published: July 30, 2024
Thiophenyl Derivatives of Nicotinamide Are Metabolized by the NAD Salvage Pathway into Unnatural NAD Derivatives That Inhibit IMPDH and Are Toxic to Peripheral Nerve Cancers.
Journal: ACS chemical biology
Published: June 03, 2024
Discovery and Optimization of N-Arylated Tetracyclic Dicarboximides That Target Primary Glioma Stem-like Cells.
Journal: Journal of medicinal chemistry
Published: May 28, 2024
Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3.
Journal: Cell chemical biology
Published: June 09, 2023
Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules.
Journal: bioRxiv : the preprint server for biology
Published: March 03, 2023
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex.
Journal: Nature communications
Published: April 02, 2022
Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production.
Journal: Cell chemical biology
Published: March 28, 2022
Last Updated: 09/26/2026